Table 3 Summary of adverse events by preferred terms (30-day safety window).
Adverse event preferred term | Any grade | Grade 3/4 |
|---|---|---|
Nausea | 25 (80.6) | 3 (9.7) |
Diarrhoea | 19 (61.3) | 1 (3.2) |
Neutrophil count decreased | 19 (61.3) | 12 (38.7) |
Peripheral sensory neuropathy | 19 (61.3) | 0 |
Decreased appetite | 18 (58.1) | 5 (16.1) |
Stomatitis | 15 (48.4) | 0 |
Constipation | 13 (41.9) | 0 |
Dysgeusia | 12 (38.7) | 0 |
Malaise | 14 (45.2) | 1 (3.2) |
Rash | 10 (32.3) | 1 (3.2) |
White blood cell count decreased | 9 (29.0) | 3 (9.7) |
Platelet count decreased | 8 (25.8) | 0 |
Alopecia | 7 (22.6) | 0 |
Fatigue | 7 (22.6) | 0 |
Hiccups | 7 (22.6) | 0 |
Pyrexia | 7 (22.6) | 0 |
